By Richard Lenti
The Food and Drug Administration has approved a new oral drug for the treatment of multiple sclerosis (MS).
Manufactured by the Cambridge, Massachusetts-based Biogen Idec (NASDAQ: BIIB), twice-a-day capsules of dimethyl fumarate will be sold under the brand name Tecfidera and should be available within the coming weeks. Biogen has not disclosed the price of the drug, but like other MS medications, monthly treatments are expected to cost tens of thousands of dollars.
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 11, 2019
April 01, 2019
March 18, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile